These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6999491)

  • 1. Assessment of diabetic control with Actrapid and Monotard insulins.
    Harrower AD; Archibald L
    Practitioner; 1980 Jun; 224(1344):657-8. PubMed ID: 6999491
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of twice daily regimens of Actrapid and Monotard insulins.
    Akintewe TA
    East Afr Med J; 1985 Mar; 62(3):196-9. PubMed ID: 3893969
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of blood glucose profile and glycemic control in type 1 diabetic patients treated with Actrapid-Monotard or Actrapid Protaphane (NPH) human insulins.
    Buysschaert M; Minette P; Ketelslegers JM; Pairet JV; Vogels M; Lambert AE
    Diabetes Res; 1987 Jan; 4(1):31-3. PubMed ID: 3552364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biological activity of semisynthetic human insulin in healthy persons and in patients with diabetes mellitus].
    Czyzyk A; Rogala H; Stepka M; Krzymień J; Szymerska E
    Pol Arch Med Wewn; 1986 Sep; 76(3):144-51. PubMed ID: 3554161
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of mixing short- and intermediate-acting insulins on absorption course and biologic effect of short-acting preparation.
    Forlani G; Santacroce G; Ciavarella A; Capelli M; Mattioli L; Vannini P
    Diabetes Care; 1986; 9(6):587-90. PubMed ID: 3542453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of insulins Novo Monotard and Lente MC].
    Scheen A; Scheen-Lavigne M; Luyckx A
    Rev Med Liege; 1979 Nov; 34(22):923-7. PubMed ID: 398067
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of efficacy and safety of human insulin (Novo) in the treatment of insulin-dependent diabetes mellitus: a double-blind, multicenter clinical trial.
    Karam J; Brink S; Clements R; Miller L; Raskin P
    Diabetes Care; 1983; 6 Suppl 1():56-60. PubMed ID: 6343041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with monocomponent insulins in management of diabetes mellitus-- a preliminary report.
    Kumar V; Ahuja MM
    J Assoc Physicians India; 1980 Oct; 28(10):361-4. PubMed ID: 7014550
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduction in insulin antibodies 42 months after transfer from porcine to human monocomponent insulins.
    Virgili F; Frigato F; Magnanini PG; Coronel GA; Iavicoli M
    Diabetes Res; 1988 Sep; 9(1):19-20. PubMed ID: 3071441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of injection techniques for soluble and protamine zinc insulins in diabetes mellitus.
    Harrower AD; Duncan LJ; Clarke BF
    Practitioner; 1975 Feb; 214(1280):228-31. PubMed ID: 1144249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human insulin.
    Roberts RJ
    Iowa Med; 1984 Mar; 74(3):116-8. PubMed ID: 6373658
    [No Abstract]   [Full Text] [Related]  

  • 12. INSULIN RAPITARD AND INSULIN ACTRAPID.
    SCHLICHTKRULL J; MUNCK O; JERSILD M
    Acta Med Scand; 1965 Jan; 177():103-13. PubMed ID: 14251842
    [No Abstract]   [Full Text] [Related]  

  • 13. What's news in insulin?
    Pepper G
    Nurse Pract; 1986 Jan; 11(1):62-3. PubMed ID: 3510406
    [No Abstract]   [Full Text] [Related]  

  • 14. [Advances in insulin treatment. Evaluation of isophane or lente insulin, mixed with rapid insulin and injected twice-a-day].
    Cucinotta D; Lunetta M
    Minerva Endocrinol; 1990; 15(2):111-6. PubMed ID: 2098651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple and rational twice daily insulin regime. Distinction between basal and meal insulin requirements.
    Phillips M; Simpson RW; Holman RR; Turner RC
    Q J Med; 1979 Jul; 48(191):493-506. PubMed ID: 396545
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymphocyte transformation by insulin and insulin-zinc suspensions.
    Diem P; Spengler H; de Weck AL
    Clin Exp Immunol; 1982 Oct; 50(1):155-62. PubMed ID: 6756727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experiences in the treatment of diabetes with insulins of monocomponent (MC) and monospecies (MS) type].
    Andreani D; Iavicoli M; Colletti A; Menzinger G
    Folia Endocrinol; 1972 Dec; 25(6):516-39. PubMed ID: 4581824
    [No Abstract]   [Full Text] [Related]  

  • 18. Alternative approach to the treatment of diabetes mellitus.
    Valuev LI; Starosel'tseva LK; Valuev IL; Vanchugova LV; Khadzhiev SN
    Dokl Biol Sci; 2017 Jan; 472(1):15-16. PubMed ID: 28429265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled study of prolonged study with semi-synthetic human insulin.
    Drury R; Keenan P; McEvoy M; Cregan D; Drury MI; Reeves WG
    Ir J Med Sci; 1983 Dec; 152(12):430-4. PubMed ID: 6365832
    [No Abstract]   [Full Text] [Related]  

  • 20. Possible differences in potency of purified pork insulins: confirmation by the euglycemic clamp technique.
    Mangan MM; Kemp FW; Akgun S; Ertel NH
    Diabetes Res; 1987 Apr; 4(4):201-5. PubMed ID: 3304784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.